Cell Biology Program

The Lydia Finley Lab

Research

Lydia Finley, PhD
Lydia Finley, PhD
Geoffrey Beene Junior Faculty Chair

The Finley Lab investigates how cellular metabolic pathways regulate cell fate decisions in stem cells and cancer cells. We combine genetic and metabolomic approaches to investigate cell-type specific growth requirements and elucidate how flux through central metabolic pathways regulates key cellular activities, including self-renewal and differentiation. In particular, we are interested in understanding how changes in metabolite availability shape the chromatin landscape to influence gene expression programs that control cell survival, growth and differentiation. Our work aims to answer fundamental questions about how cells regulate the commitment to differentiation and how failure to execute terminal differentiation can underlie diseases such as cancer.

VIDEO | 02:00
Go inside the lab of Lydia Finley from SKI's Cell Biology Program.
Video Details
The Lydia Finley Lab

Featured News

A colorful pigeon standing in an urban setting.
SKI Scientists Discover a New Twist on an 80-Year-Old Biochemical Pathway
With the resurgence of interest in cancer metabolism, researchers are coming to realize that there is more to a cell’s biochemistry than once thought.
In Brief
A fluorescent image of cells undergoing differentiation in a mouse model.
Cancer Stem Cells’ Reliance on a Key Amino Acid Could Be an Exploitable Weakness
The discovery links metabolism to the way cancer stem cells form tumors.
In the Lab
illustration of the p53 protein binding to a DNA helix
New Findings Clarify How the “Guardian of the Genome” Works
Surprise! It has to do with metabolism.

Publications Highlights

A non-canonical tricarboxylic acid cycle underlies cellular identity. Arnold PK, Jackson BT, Paras KI, Brunner JS, Hart ML, Newsom OJ, Alibeckoff SP, Endress J, Drill E, Sullivan LB, Finley LWS. Nature. 603: 477-481. 2022.

Amino acid intake strategies define pluripotent cell states. Todorova PK, Jackson BT, Garg V, Paras KI, Chen Y, Baksh SC, Yan J, Hadjantonakis, A, Finley LWS. Nature Metabolism. 6: 127-140. 2024.

View All Publications

People

Lydia Finley, PhD

Lydia Finley, PhD

Geoffrey Beene Junior Faculty Chair

  • Lydia Finley studies the mechanisms that link metabolic pathways to cell fate decisions.
  • PhD, Harvard University
  • BS, Yale University
finleyl@mskcc.org
Email Address
212-639-6722
Office Phone

Members

Julia Brunner
Julia Brunner
Research Fellow
Abigail Xie
Graduate Student
Natasha Freidman
Research Fellow
Sonia Das
Sonia Das
Sr. Administrative Assistant
Sangita Chakraborty
MSK Bridge Program Scholar
mk
Monika Komza
Graduate Student
Joycelyn Tan
Research Fellow
Xianbing Zhu
Research Fellow
Angela Montero
Graduate Student
Pavlina Todorova, PhD
Pavlina Todorova
Research Associate
Paige Arnold
Paige Arnold
Postdoctoral Associate at Rockefeller University, New York, NY
Yanyang Chen
Yanyang Chen
Research Technician
Jossie J Yashinskie
Jossie J Yashinskie
Graduate Student
Katrina Paras
Katrina Paras
Graduate Student
Benjamin Jackson
Benjamin Jackson
Graduate Student
Yuma Tada
Yuma Tada
Graduate Student
Sanjeethan Baksh
Sanjeethan Baksh
Medical Resident
Anna
Anna Bridgeman
MSK Bridge Program Scholar
MF
Maider Fagoaga-Eugui
Graduate Research Assistant
Lin Hedehus
Graduate Research Assistant
Angela Montero
Graduate Student

Achievements

  • Tsuneko and Reiji Okazaki Award (2024)
  • New York Stem Cell Foundation – Robertson Investigator (2023)
  • Louise and Allston Boyer Young Investigator Award for Basic Research (2022)
  • National Cancer Institute R37 MERIT Award (2020)
  • Pershing Square Sohn Prize for Cancer Research (2020)
  • Searle Scholar (2018)
  • Dale F. Frey Breakthrough Award of the Damon Runyon Cancer Research Foundation (2017)

Lab News & Events

Accolades

Team Recognitions

  • Benjamin Jackson, Olaf S. Anderson Physician-Scientist Award (2024)
  • Julia Brunner, Kravis WiSE Fellowship (2024)
  • Abby Xie, NIH/NCI F31 (2023)
  • Paige Arnold, Gerstner Sloan Kettering Chairman’s Prize (2022)
  • Paige Arnold, Weintraub Award (2022)
  • Sanjeethan Baksh, STAT Wunderkind (2022)
  • Benjamin Jackson, NIH/NICHD F31 (2022)
  • Katrina Paras, Bruce Charles Forbes Pre-Doctoral Fellowship (2021)
  • Benjamin Jackson, Gerstner Sloan Kettering Grayer Fellowship (2021)
  • Julia Brunner, Human Frontier Science Program Fellowship (2021)
  • Sanjeethan Baksh, Olaf S. Anderson Physician-Scientist Award (2021)
  • Paige Arnold, NIH/NICHD F31 (2019)
  • Jossie Yashinskie, AACR Minority Scholar in Cancer Research Award (2018)
  • Jossie Yashinskie, NIH/NICHD T32 fellowship (2018)

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Career Opportunities

Apply now

Get in Touch

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Lydia Finley discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures